Form D · Biotechnology
Laza Medical, Inc.
Campbell, CA · CIK 0002003996
Offering snapshot reported Dec 13, 2023 · SEC filing
- Reported sold
- $25.5M Offering amount: $38.3M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $26.1K Reported outside-investor minimum
- First sale
- Nov 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2023 | Initial | $25,463,112 | No comparison | 45 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-499539
Source: Form D, filed Dec 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Casey Gordon | Director |
| Pablo Garcia Kilroy | Director |
| Mariam Maghribi | Executive |
| Amr Salahieh | Director, Executive, Promoter |
| David Voris | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
590 Division Street
Campbell, CA, 95008
Campbell, CA, 95008